title: [Changes in the spectral characteristics of ventricular fibrillation in lesions produced by radiofrequency ablation. An experimental study].
abstract: OBJECTIVE
  Although electro- physiological databases contain information about changes in the time domain in lesions produced by radiofrequency ablation, very few data on changes in the frequency domain are available. The aim of this study was to investigate changes in the spectral characteristics of ventricular fibrillation in zones with radiofrequency lesions.
  
  
  METHODS
  Recordings of ventricular fibrillation were obtained in 11 isolated perfused rabbit heart preparations using a multiple epicardial electrode located on the left ventricular free wall. Spectral parameters derived by Fourier analysis before and after the creation of transmural radiofrequency lesions were compared.
  
  
  RESULTS
  In the ablated zones, significant reductions were observed in the spectral density of the dominant (0.168+/-0.113 mV(2)/Hz vs 0.025+/-0.018 mV(2)/Hz; P< .001) and mean frequencies (0.053+/-0.057 mV(2)/Hz vs 0.012+/-0.016 mV(2)/Hz; P< .001), the normalized energy around the dominant frequency (0.860+/-0.570 vs 0.128+/-0.091; P< .001), and the standard deviation of the power spectrum (0.031+/-0.020 mV(2)/Hz vs 0.004+/-0.001 mV(2)/Hz; P< .001). There was no significant change in the dominant (16.2+/-5.6 vs 14.8+/-1.8 Hz) or mean frequency (17.7+/-3.4 vs 16.6+/-1.3 Hz). The spectral parameters that could be used in a multivariate model to identify the lesion were the standard deviation of the power spectrum and the spectral density of the mean frequency.
  
  
  CONCLUSIONS
  During ventricular fibrillation, the spectral parameters associated with spectral power and spectral energy were significantly altered in zones with radiofrequency lesions and could be used to identify those zones. There was no significant change in either the dominant or mean frequency in these zones.
authors.affiliation: Departamento de Medicina, Universidad de Valencia (UVEG), Valencia, España. Francisco.J.Chorro@uv.es
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Chorro
authors.forename: Juan
authors.initials: J
authors.lastname: Guerrero
authors.forename: Joaquín
authors.initials: J
authors.lastname: Cánoves
authors.forename: Isabel
authors.initials: I
authors.lastname: Trapero
authors.forename: Luis
authors.initials: L
authors.lastname: Mainar
authors.forename: Francisca
authors.initials: F
authors.lastname: Pelechano
authors.forename: Estrella
authors.initials: E
authors.lastname: Blasco
authors.forename: Luis
authors.initials: L
authors.lastname: Such-Miquel
authors.forename: Angel
authors.initials: A
authors.lastname: Ferrero
authors.forename: Juan
authors.initials: J
authors.lastname: Sanchis
authors.forename: Vicente
authors.initials: V
authors.lastname: Bodí
authors.forename: José M
authors.initials: JM
authors.lastname: Cerdá
authors.forename: Antonio
authors.initials: A
authors.lastname: Alberola
authors.forename: Luis
authors.initials: L
authors.lastname: Such
mesh_terms: D000818:Animals; D017115:Catheter Ablation / Q000009:adverse effects*; D006352:Heart Ventricles / Q000293:injuries* / Q000503:physiopathology*; D066298:In Vitro Techniques; D011817:Rabbits; D014693:Ventricular Fibrillation / Q000503:physiopathology* / Q000601:surgery*